InHealth Ventures

What is InHealth Ventures?

InHealth Ventures is a venture capital firm that operates as the venture arm of InHealth Group, a leading UK specialist provider of diagnostic and healthcare solutions. With headquarters in Colonnade Walk, 123 Buckingham Palace Rd, Victoria, London, their mission is to partner with innovative entrepreneurs focused on building healthcare technology and services companies that address significant healthcare challenges. The firm shows a strong preference for co-investing in early-stage funding rounds, primarily in seed and Series A deals, alongside other institutional leads.

They possess a unique investment thesis that revolves around an early stage, transatlantic healthcare fund, which demonstrates their expansive scope across North America, Europe, and Asia. Their stated commitment is to long-term collaboration with their portfolio companies, underpinning the belief that substantial impact in healthcare requires time and patience. InHealth Ventures differentiates itself through leveraging its team's comprehensive experience in healthcare, offering portfolio companies a distinct mix of perspectives and capabilities to scale.

They benefit from the backing of InHealth, giving them access to an extensive network of clinical leaders and industry operators, enhancing their ability to support portfolio companies through product development and go-to-market strategies. A key focus for InHealth Ventures is aiding companies in scaling to new markets, with an end-goal of global improvement in healthcare. This venture capital fund emphasizes equity investments within the range of GBP 9,690,000, showing both their commitment level and financial threshold for individual investments.

Their specialties include Seed, Startup, Early Stage, and Series A investments. InHealth Ventures is known for providing in-depth support based on real-world experience, reflecting their unique approach to health tech companies and startup growth trajectories.

What they say:

We support those advancing medical science and patient care.

What we look for: We invest in "healthcare" pioneers.